Clinical trials group Hvivo announces departure from Irish stock market
Company says its primary operations, along with the majority of its employees and investor base, are based in the UK
Company says its primary operations, along with the majority of its employees and investor base, are based in the UK
The best news, analysis and comment from The Irish Times business desk
Cathal Friel shows no sign of slowing down after a busy week which saw him sell his remaining stake in Hvivo
Businessman oversaw the initial flotation in 2019 of clinical trials group that became Hvivo
Company’s Canary Wharf facility provides scope for growth
Group says establishment of a Covid challenge model is a key step to penetrating a new and expanding market
Company says it will begin paying annual dividends
New and existing institutional investors indicated demand for shares was in excess of those available
Pharmaceutical services company is testing drug for human rhinovirus in human challenge trial
Company, formerly known as Open Orphan, described the first half of 2023 as ‘another period of excellent growth’
Dublin- and London-listed pharma services company has seen its order book grow 11% in first half from same period in 2022
Deal is Dublin-listed pharma company's first in the region in over 10 years
Company expects revenues from the contract to be recognised across 2022 and 2023
Bavarian Nordic vaccine candidate used hVivo challenge trial to gather data
Executive chairman Cathal Friel said Hvivo expects to sign a number of similar contracts
Healthy volunteers are administered a pathogenic or virulent strain of virus
hVivo will develop a new SARS-CoV-2 challenge virus based on new emerging variants
Contract with US biotechnology company concerns a respiratory syncytial virus
Irish clinical trials group will deliberately infect healthy young volunteers with virus
Guidelines will cover manufacture of agents for use in controlled infection studies
Contract with UK government could be worth up to £10m
Open Orphan’s hVivo unit will conduct world’s first human challenge trials of several vaccine candidates
Dublin listed company will carry out phase one trial at Hvivo facility
London subsidiary Hvivo will carry out testing at its lab with 48-hour turnaround
Issues with everything from drug trials to tech solutions, patient care are being tackled
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices